Fintel reports that on November 20, 2025, JP Morgan initiated coverage of OPKO Health (NasdaqGS:OPK) with a Neutral recommendation. Analyst Price Forecast Suggests 185.76% Upside As of November 17, ...

Opko Health Inc. (NASDAQ:OPK) is one of the best stocks under $5 with highest upside potential. ModeX Therapeutics Inc., an Opko Health Inc. (NASDAQ:OPK) company, announced on October 29 a license and ...

OPKO Health (OPK) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.03 per share a year ago. These ...

Good day, and welcome to the OPKO Health Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the ...

Opko Health Inc. (NASDAQ:OPK) is one of the 13 Stocks Under $5 With High Upside Potential. On May 1, analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on Opko Health Inc. (NASDAQ:OPK), ...

OPKO Health, Inc. (NASDAQ:OPK) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 25, the company, in partnership with Entera Bio Ltd., announced that new data for ...

OPKO and Entera Bio collaborate to develop an oral dual agonist for obesity and metabolic disorders, aiming for FDA application soon. OPKO Health, Inc. and Entera Bio Ltd. have announced a ...

Good day. And welcome to the OPKO Health Fourth Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, ...

$OPK insiders have traded $OPK stock on the open market 9 times in the past 6 months. Of those trades, 9 have been purchases and 0 have been sales. Here’s a ...